Antimicrobial peptides are an important part of the innate immune defense in the central nervous system (CNS). The expression of the antimicrobial peptides psoriasin (S100A7) is up-regulated during bacterial meningitis. However, the exact mechanisms induced by psoriasin to modulate glial cell activity are not yet fully understood. Our hypothesis is that psoriasin induced pro-and anti-inflammatory signaling pathways as well as regenerative factors to contribute in total to a balanced immune response. Therefore, we used psoriasin-stimulated glial cells and analyzed the translocation of the pro-inflammatory transcription factor nuclear factor 'kappa-light-chainenhancer' of activated B-cells (NFjB) in murine glial cells and the expression of pro-and anti-inflammatory mediators by real time RT-PCR, ELISA technique, and western blotting. Furthermore, the relationship between psoriasin and the antioxidative stress transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) was investigated. Stimulation with psoriasin not only enhanced NFjB translocation and increased the expression of the pro-inflammatory cytokines, interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) but also neurotrophin expression. Evidence for functional interactions between psoriasin and Nrf2 were detected in the form of increased antioxidant response element (ARE) activity and induction of Nrf2/ARE-dependent heme oxygenase 1 (HO-1) expression in psoriasin-treated microglia and astrocytes. The results illustrate the ability of psoriasin to induce immunological functions in glia cells where psoriasin exerts divergent effects on the innate immune response.
Both glia cells, astrocytes as well as microglial cells, mediate the innate immune response in the central nervous system (CNS). The resident microglia and astrocytes exert multiple functions in the CNS, including protective and restorative effects in response to CNS infection or injury (Ransohoff and Brown 2012) . They produce and release inflammatory mediators such as cytokines that recruit cells of the adaptive immunity (Farina et al. 2007; Mariani and Kielian 2009) . Beside these mediators, glial cells express antimicrobial peptides (AMPs), which are an important part of the innate immune system and are involved in the first line of the immune defense . In addition to their role as endogenous antibiotics, AMPs influence several aspects of the immune system, for example, they are involved in septic and non-septic inflammatory processes, wound healing, angiogenesis, and the regulation of the specific immune system (Bucki et al. 2010; Brandenburg et al. 2012) . Our previous results emphasized the importance of the AMP cathelin-related antimicrobial peptide (CRAMP) in bacterial infection in the CNS. Lack of CRAMP resulted in an increased mortality and aggravated inflammation after pneumococcal meningitis (Merres et al. 2014) . Another antimicrobial protein class that is considered as an important part of the skin barrier function is the S100 proteins. Psoriasin (aliases S100A7c, S100A7) is an important member of the S100 family that belongs to the calcium-binding proteins which contains an EF-hand motif for calcium binding (Heizmann et al. 2002) . In a recent work, we revealed increased psoriasin levels in the cerebrospinal fluid (CSF) from patients with bacterial meningitis. In a rat model of pneumococcal meningitis, the infection induced the expression of koebnerisin (alias S100A15), the ortholog of human koebnerisin and psoriasin, in astrocytes and meningeal cells (Jansen et al. 2013) .
Next to their direct antimicrobial function, AMPs exert important immunomodulatory effects. Koebnerisin and psoriasin are considered leukocyte-derived systemic mediators involved in inflammation in psoriasis (Batycka-Baran et al. 2015) . Furthermore, psoriasin enhances the expression of keratinocyte differentiation markers and increases the expression of tight junction proteins of the skin barrier (Hattori et al. 2014) . We suggested an important role for psoriasin in the CNS where it induced morphological changes in microglial cells toward an enlarged shape and an increase in the signal-regulated kinase 1/2 (ERK1/2) signal transduction pathway (Jansen et al. 2013) .
Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a central role in cellular defense against oxidative stress by induction of anti-oxidative enzymes. The 5 0 -flanking regions of genes encoding these antioxidative enzymes contain a specific consensus sequence termed antioxidant response element (ARE) . Recent studies have demonstrated that Nrf2/ ARE signaling is involved in attenuating inflammationassociated pathogenesis including autoimmune diseases like rheumatoid arthritis, asthma, gastritis, colitis, and atherosclerosis (Brandenburg et al. 2009; Wruck et al. 2011a; Dang et al. 2012; O'Connell and Hayes 2015) . Therefore, Nrf2 was in the focus of research as a pharmacological target that could be used for the prevention and treatment of inflammatory diseases (Al-Sawaf et al. 2015) . Activation of Nrf2 was shown to exert positive effects in animal models of multiple sclerosis and stroke (Draheim et al. 2016; Yamauchi et al. 2016) .
This study was designed to determine the influence of psoriasin on glial cell activity using primary murine wildtype glial cells. We investigated the induction of proinflammatory markers including the translocation of the transcription factor nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NFjB) to the cell nucleus and cytokine expression in glial cells after exposure to psoriasin. Additionally, the anti-inflammatory response and potential neuroprotective functions of psoriasin were analyzed by determining the protein expression of the anti-inflammatory enzyme heme oxygenase 1 (HO-1) and the expression of neurotrophins. Furthermore, a possible functional interaction in glial cells between psoriasin and Nrf2 was evaluated.
Materials and methods

Reagents and stimulation
Lipopolysaccharide (LPS) from Salmonella typhimurium was subsequently applied at a concentration of 100 ng/mL (Sigma Aldrich, Steinheim, Germany). Recombinant psoriasin was expressed as described in Michalek et al. (Michalek et al. 2009 ). In order to estimate the LPS amount of the recombinant psoriasin, the EndoLISA endotoxin ELISA from Hyglos (Hyglos, Bernried, Germany) was used according to manufacturer's instructions. Since recombinantly expressed psoriasin was produced in E. coli, we first estimated the LPS content of the protein. A psoriasin stock solution of 1 mg/mL was diluted 1 : 10 and 1 : 100, corresponding to 100 lg/mL and 10 lg/mL protein. The samples were subjected to an ELISA to estimate the LPS content. In both samples, the LPS content was 10 times lower than the lowest concentration used for calibration which corresponds to a LPS content of < 0.03 U/lg protein. Cells were stimulated with psoriasin at specified concentrations (100-500 ng/mL). For positive control of Nrf2 activation, cells were treated with 6.25 lM sulforaphane (Sigma Aldrich).
Cell culture
All experiments were performed in accordance with the German protection of animals act and with permission of the authority of the federal state North Rhine Westphalia. The study protocol was approved by the institutional animal care. Isolated cerebral cortices and rostral mesencephali from 2-day-old C57/BL6 mice pups of both genders, which were bred in the Animal Facility of the University Hospital Aachen, were stripped of the meninges. Cortices and mesencephali were minced and dissociated enzymatically with trypsin from bovine pancreas (Sigma Aldrich, Steinheim, Germany) in phosphate-buffered saline and 1 mg/mL DNase (Thermo Fisher Scientific, Wesel, Germany) for 30 min at 37°C and crushed mechanically with scalpels. Astrocytes were cultivated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Sigma Aldrich) and 1% penicillin and streptomycin (Sigma) according to the method of Mc Carthy and Devellis (McCarthy and de Vellis 1980) . Contaminated microglial cells were removed by preplating the cells on plastic dishes for 5-10 min and discarding the unattached cells. Microglial cells were collected from the medium of primary cell cultures of astrocytes. As culture medium, we used microglial cell growth medium [DMEM contains 10% FBS (heat inactivating from 44 to 53°C)] and antibiotics (penicillin and streptomycin). After about 10 days, microglial cells detached from the adherent cells. The cells were collected by centrifugation of the supernatants and then seeded in normal medium (DMEM, 10% FBS heat inactivated at 56°C, penicillin and streptomycin). Prior to replating microglial cells for different assays, cell number and viability were estimated by trypan blue exclusion (Oldekamp et al. 2014) . Purity of primary glial cell cultures was determined by immunocytochemistry with either polyclonal rabbit anti-glial fibrillary acidic protein (1 : 9000; EnCor, Gainesville, FL, USA) or anti-Iba1 (ionized calcium-binding adaptor molecule 1; 1 : 10 000; Wako, Neuss, Germany). Astrocytes cultures contained < 3% Iba1 + microglial cells and the microglial cell culture, < 2% glial fibrillary acidic protein + astrocytes (values are given as arithmetic mean of n = 3 experiments + SEM).
The treatment of the glial cells was performed in serum-free DMEM medium. At least 3 h before treatment started, the medium was exchanged for serum-free medium.
Fluorescence microscopy Primary mice astrocytes or microglia were seeded on cover glasses and stimulated for 5 min up to 6 h with psoriasin or LPS. Slices were incubated at 4°C with the following antibody: NFjB p65 (4764S, Cell Signaling Technology, Beverly, MA, USA). Finally, the slices were incubated with anti-rabbit Cy3 (AP132C, Millipore, Darmstadt, Germany) for 1 h at 25°C. Nuclear counterstaining was performed with diamidino-2-phenylindole dihydrochloride (Sigma 9542). Cells were digitally photographed using a Keyence digital microscope (BZ-9000, Germany). To evaluate the increase in fluorescence, the relative fluorescence intensity from the ratio of the corresponding fluorescence intensity of the glial cells compared to the untreated controls was calculated. The fluorescence intensity was evaluated blindly and randomized. Altogether, per treatment, at least 20 images of four independent approaches were evaluated.
Preparation of lentiviral particles and transduction of target cells Lentiviral particles were produced in HEK293T cells. Transfection was performed using jetPEI reagent (Peqlab, Erlangen, Germany). A second generation lentiviral plasmid system containing the lentiviral transfer vector (SIN-lenti-NFjB, SIN-lenti-ARE, pLKO.1-shNrf2 or pLKO.1-Non-Target), the packaging vector (psPAX2: a gift from Didier Trono, School of Life Sciences, Ecole Polytechnique F ed erale de Lausanne, Laboratory of Virology and Genetics, Lausanne, Switzerland; addgene plasmid #12260), and the envelope protein (pMD2.G: a gift from Didier Trono, addgene plasmid #12259) (Addgene, Germany) was used. To obtain the transfer vector, we initially excluded the 7 9 TCF (T-cell factor) sequences of the 7TFP plasmid (a kind gift from Roel Nusse, Department of Developmental Biology, Howard Hughes Medical Institute, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; addgene plasmid #24308) by enzymatic restriction using PstI and NheI. Afterward, either the concatenated trimer of the wild-type NFjB RE sequence (SIN-lenti-NFjB) or the antioxidant response element (SIN-lenti-ARE) consensus sequence of the rat NADP(H) dehydrogenase, quinine 1 promoter region [as also used in ] were introduced by standard cloning techniques instead. Test restriction, gel electrophoresis and DNA sequencing verified resulting plasmid DNA. The transfection mix was applied as recommended by the manufacturer. The viral particles were harvested and concentrated by ultra-centrifugation 48 h after transfection. The Non-Target shRNA vector is produced from the sequence-verified lentiviral plasmid vector containing nontargeting shRNA. The MISSION pLKO.1-puro Non-TARGET shRNA Control was obtained from Sigma-Aldrich (Catalog No. SHC016).
Transduction was conducted in standard culture medium (2 mL) using 5 9 10 5 target cells (primary murine astrocytes and microglia, respectively) per well of a 6-well plate. Viral content with a multiplicity of infection of 10 was added to the cells 1 day after seeding. After transduction (16 h), the cells were washed with phosphate-buffered saline and cell culture medium was replaced. The cells were stimulated subsequently as described above.
Luciferase reporter gene assay After transduction, 5 9 10 4 Cells/well were seeded in a 96-well plate and treated after adherence as already described. Cells were lysed as recommended by the manufacturer using the passive lysis buffer system (Promega, Madison, WI, USA) provided by the applied assay kit. The determination of NFjB-or ARE-dependent luminescence signals, respectively, was achieved with the luciferase assay system (E1501, Promega, Mannheim, Germany) in a 96-well luminometer (GloMaxâ-96 microplate Luminometer, Promega).
The raw luminescence signals were normalized to corresponding bicinchoninic acid assay (BCA assay; Thermo Fisher Scientific, Wesel, Germany) data, which was conducted in parallel with same samples. Normalized data were related to control group whereby results are depicted as x-fold of control.
ELISA
Astrocytes and microglia were stimulated with psoriasin or LPS at different time points. Interleukin-6 (IL-6) and tumor necrosis factora (TNF-a) concentration of the cell culture supernatant were measured with ELISA technique. The ELISA kit specific for IL-6 and TNF-a was purchased from R&D Systems (R&D DuoSet, Wiesbaden-Nordenstadt, Germany).
Western blotting
Cells were harvested in a lysis buffer. Proteins were detected by means of BCA assay. Proteins (5 lg) were resolved in sodium dodecyl sulfate (SDS) sample buffer and a western blotting procedure was performed. Membranes were incubated with polyclonal against HO-1 (ab13243; Abcam, Cambridge, UK) or b-Actin (sc-47778, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4°C. The detection was performed with peroxidaselabeled secondary antibodies. Antibody binding was detected via enhanced chemiluminescence (Millipore). The density of the bands was evaluated via Image J. The ratio between the protein and corresponding loading control bands (b-Actin) was calculated. The experiments were performed in triplicate.
RNA isolation and real time RT-PCR
Total RNA was isolated using the peqGold Trifast reagent (Peqlab, Erlangen, Germany) according to the manufacturer's instructions. RNA samples were reverse-transcribed by moloney murine leukemia virus reverse transcriptase (Fermentas, Burlington, Canada) and random hexamer primers (Invitrogen, Darmstadt, Germany). The cDNA products were used immediately for SYBR green (Applied Biosystems, Darmstadt, Germany) real time RT-PCR (Reverse transcription polymerase chain reaction). Gene expression was monitored using the StepOne Plus apparatus (Applied Biosystems) according to the manufacturer's protocol.
Relative quantification was performed using the DCt method, which results in ratios between target genes and a housekeeping reference gene index including [TATA-box binding protein (TBP)]. The primers were manufactured by Eurofins MWG Operon (Ebersberg, Germany; for primer sequences of TBP, interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a) see (Merres et al. 2014 ); brain-derived neurotrophic factor (BDNF), Nrf2, IL-10 or nerve growth factor (NGF) ( Table 1 ). The specificity of the amplification reaction was determined by melting curve analysis. Each probe was analyzed as duplicate.
Statistical analysis
All measurements were performed at least in three independent experiments and the values represent mean AE SEM. Significance of the difference between test and control groups was analyzed using one-way, two-way ANOVA followed by the Bonferroni's multiple comparison post hoc or Student's t-test as described in the figure legend. Statistical analyses were carried out with GraphPad Prism 5 Software (GraphPad Software Inc., San Diego, CA, USA). Differences were considered statistically significant at p < 0.05. All efforts were made to avoid animal suffering and to use the minimum number of animals allowed by the experimental protocol.
Results
Increased nuclear NFjB p65 translocation in astrocytes and microglia after stimulation with psoriasin At first, the translocation of the pro-inflammatory transcription factor and important regulator of innate immune response, NFjB p65, in the nucleus of astrocytes and microglia after treatment with psoriasin was investigated by immunofluorescence detection. In untreated astrocytes, no relevant NFjB p65 immunoreactivity was observed in the cell nucleus (Fig. 1a ). Astrocytes treated with LPS (100 ng/ mL) for 15 min as positive control showed a very strong NFjB p65 staining. Cells exposed to 300 ng/mL psoriasin for different time periods showed a strong increase in NFjB p65 immunoreactivity in the cell nucleus after 15 and 30 min of treatment. To evaluate the increase in fluorescence, the relative fluorescence intensity from the ratio of the corresponding fluorescence intensity of astrocytes compared to the untreated controls was calculated (Fig. 1b) . For LPS and psoriasin, the treatment of astrocytes with both components resulted in a significant increase in NFjB p65 translocation from 15 min to 2 h with a maximum after 30 min. After 6 h of treatment, the NFjB p65 translocation fell to control levels. Next, we analyzed the NFjB p65 translocation in microglial cells ( Fig. 2a and b) . Similar to astrocytes, quantification in microglial cells revealed a significant increase in NFjB p65 translocation from 15 min to 2 h with a maximum after 30 min of LPS treatment. For psoriasin, the treatment also led to a significant increase in NFjB p65 translocation after 30 min up to 2 h with a maximum after 30 min. Again, after 6 h of exposure, the translocation fell to levels comparable to controls in microglial cells (Fig. 2b) .
To confirm these immunohistochemical results, the NFjB activity in astrocytes and microglial cells was analyzed using luminometer assay. Cells were transduced with the SIN-lentiNFjB construct to visualize NFjB activity via luciferase activity. As shown in Figs 1c and 2c, LPS as positive control significantly induced NFjB activity in both astrocytes and microglia with a maximum after 30 min. Similarly, psoriasin also induced a significant increase in NFjB activity in astrocytes and microglia from 15 min to 2 h with a maximum after 30 min after treatment. After 6 h of psoriasin treatment, the NFjB activity reached control levels of astrocytes or microglia. Taken together, psoriasin had a power to induce NFjB activity similar to that of LPS.
Psoriasin-induced pro-inflammatory cytokine expression in astrocytes and microglial cells
The transcription factor NFjB coordinates the expression of several factors controlling the immune response including pro-inflammatory cytokine synthesis (Li and Verma 2002) . Therefore, we analyzed the secretion of the pro-inflammatory cytokines IL-6 and TNF-a in primary astrocytes and microglial cells after stimulation with psoriasin (300 ng/ mL) or LPS (100 ng/mL) as positive control for different time periods. Protein expression was quantified using ELISA. In astrocytes, IL-6 concentration peaked after 4 h of stimulation with psoriasin. LPS treatment induced comparable amounts of IL-6 in astrocytes with a maximum after 4 and 6 h (Fig. 3a) . After 12 h of stimulation with both psoriasin and LPS, no relevant amounts of IL-6 were any longer detectable in comparison to untreated controls. In microglial cells, the maximum increase in IL-6 protein was also detected after 4 h and 6 h of psoriasin and LPS treatment (Fig. 3b) . The analysis of TNF-a protein in the supernatants of psoriasin or LPS-treated astrocytes showed a maximum increase after 4 h compared to untreated cells (Fig. 3c) . Similar to IL-6, no relevant TNF-a levels were detectable after 12 h for both stimulants in astrocytes (Fig. 3c) . In microglia, psoriasin induced a maximal increase in TNF-a protein expression after 6 h (Fig. 3d) . In comparison, the increase in TNF-a protein expression was stronger after LPS treatment but also reached its maximum after 6 h of stimulation.
In addition to the protein expression results of the ELISA experiments, real time RT-PCR analysis was performed to analyze the time course of IL-6 and TNF-a mRNA expression in astrocytes and microglia after psoriasin (300 ng/mL) and LPS (100 ng/mL) exposure. Similar to protein expression, mRNA expression of IL-6 reached maximum levels after 6 h of psoriasin treatment in astrocytes and microglia ( Fig. 4a and b) . LPS caused a similar increase and time course of IL-6 with a maximum after 6 h of stimulation ( Fig. 4a and b) . While IL-6 reached its maximum after 6 h, TNF-a mRNA expression was highest in astrocytes after 12 h of psoriasin exposure. LPS induced a maximum expression of IL-6 and TNF-a after 6 h of treatment ( Fig. 4c  and d ). In microglia, psoriasin and LPS induced a maximum increase in TNF-a mRNA expression after 6 h of treatment (Fig. 4d) . After 24 h of treatment, IL-6 and TNF-a mRNA expression had declined to control levels. To analyze whether the measured increase in cytokine expression was a direct or indirect effect of soluble mediators produced rapidly by the psoriasin-or LPStreated cells, microglial cells were exposed with 300 ng/mL psoriasin or 100 ng/mL LPS for 6, 12, and 24 h. Afterward, the mRNA expression of cytokines and antiinflammatory cytokines were determined. Additionally, experiments with utilized conditioned media from psoriasin-or LPS-challenged microglia were carried out. Microglial cells were exposed for 16 h with psoriasin or LPS and supernatants were used as conditioned media. LPS induced a direct and indirect increase in TNF-a mRNA levels, whereas psoriasin induced only a direct increase in TNF-a mRNA expression after 6 h of treatment ( Fig. 5a  and b) . LPS treatment led to a significant increase in the anti-inflammatory cytokine IL-10 mRNA expression after 12 and 24 h, whereas psoriasin induced only a weak expression after 24 h without reaching statistical significance (Fig. 5c ). The treatment with LPS-conditioned media Fig. 1 IncreasednuclearNFjBtranslocation in primary astrocytes after stimulation with psoriasin. (a) Astrocytes were stimulated with psoriasin (300 ng/mL) or lipopolysaccharide (LPS) (100 ng/mL) for indicated time periods. After incubation, astrocytes were fixed and immunolabeledusinganti-NFjBp65antibody (red) and nuclear counter-staining diamidino-2-phenylindole dihydrochloride (DAPI) (blue) and examined with double fluorescence microscopy. The figure shows representative results from one of twenty independent pictures from four independent experiments. Scalebar = 20 lm.(b)Fluorescenceintensity wascalculated astheratio ofuntreatedcontrol cells (c) and stimulated cells. Data represent mean + SEM;n = 4.(c)Astrocytesweretrans duced with SIN-lenti-NFjB. The transduced cells were stimulated with recombinant psoriasin (300 ng/mL) or LPS (100 ng/mL) fordifferenttimeperiods.Afterward,theNFjBdependent luminescence was measured in a luminometer.Rawluminescencesignalswere normalized by bicinchoninic acid (BCA) assay toensureequalloading.Datawerethenrelated to control (Data represent mean + SEM; n = 4). n.s. = not significant; *p < 0.05; **p < 0.01; ***p < 0.001, significant difference compared to control as determined using one-way ANOVA test followed by Bonferroni 0 s multiple comparison post hoc test.
resulted in a strong increase in IL-10 mRNA expression with peaks after 6 and 12 h of stimulation. Treatment with psoriasin-conditioned media, however, induced only a weak expression after 24 h without reaching statistical significance (Fig. 5d ).
Psoriasin-induced Nrf2/ARE activity in microglia Inflammation generally induces AMP expression such as psoriasin or CRAMP and in parallel, also protective mechanisms such as the antioxidative transcription factor Nrf2 (O'Connell and Hayes 2015). Therefore, we analyzed a possible relation between psoriasin and Nrf2 in microglial cells. For that purpose, microglial cells were transfected with the lentiviral plasmid SIN-lenti-ARE (antioxidative response element) to analyze Nrf2 activity (Wruck et al. 2011b) . In order to investigate the effects on Nrf2/ARE activity, we carried out a luciferase reporter gene assay with the ARE sequence after stimulation of microglial cells with 300 ng/mL psoriasin for 6, 12, and 24 h. Additionally, microglial cells were treated with sulforaphane (SFN; 6.25 lM), an isothiocyanate obtained from cruciferous vegetables such as broccoli, as positive control (Brandenburg et al. 2009). After 6 h without stimulation, no increase in Nrf2/ARE activity was detected (Fig. 6a) , whereas psoriasin and SFN significantly induced Nrf2 activity after 12 h of stimulation (Fig. 6b) and still slightly increased after 24 h of stimulation (Fig. 6c) .
Psoriasin mRNA expression is induced in astrocytes by Nrf2 activators, methysticin and sulforaphane A nucleotide sequence analysis on NCBI identified the ARE sequence in the promoter of hPsoriasin and mPsoriasin were stimulated with recombinant psoriasin (300 ng/mL) or LPS (100 ng/mL) for different time periods. Afterward, the NFjB-depend luminescence was measured in a luminometer. Raw luminescence signals were normalized by bicinchoninic acid (BCA) assay to ensure equal loading. Data were then related to control (Data represent mean + SEM; n = 4). n.s. = not significant; *p < 0.05; ***p < 0.001; one-way ANOVA test followed Bonferroni 0 s multiple comparison post hoc test.
( Fig. 7a ). This result indicates that psoriasin is a possible target gene of Nrf2. To elucidate the involvement of Nrf2 during psoriasin mRNA expression, cells were treated with SFN and methysticin as Nrf2 activators for 24 h (Wruck et al. 2008) . Astrocytes treated with SFN (from 0.5 to 3 lM SFN) or methysticin (from 10 to 100 lM) displayed significantly increased psoriasin mRNA levels with a maximum increase after treatment with 1 lM SFN (Fig. 7b) or 50 lM methysticin (Fig. 7c) . In contrast to astrocytes, no increase in psoriasin mRNA levels was detected in microglia after treatment with SFN or methysticin ( Fig. 7d and e) .
Psoriasin treatment increased the protein expression of the anti-inflammatory enzyme HO-1
The activation of Nrf2/ARE signal pathways results in an induction of a battery of protective genes encoding antioxidant enzymes including HO-1 (Kweider et al. 2011) . Therefore, we analyzed the protein expression of HO-1 as an important Nrf2 target gene after psoriasin treatment in astrocytes and microglial cells. Cells were treated with different concentrations of recombinant psoriasin (from 100 to 500 ng/mL) for 24 h and HO-1 protein expression was determined by western blotting. As shown in Fig. 8a and b, psoriasin treatment induced a strong increase in HO-1 protein synthesis in both astrocytes and microglia. To quantify the results, the western blots were analyzed by densitometric quantification. The results revealed a maximum increase in HO-1 protein expression after treatment with 300 ng/mL psoriasin in astrocytes (Fig. 8c) and 500 ng/mL psoriasin in microglial cells (Fig. 8d) . Next, the mRNA expression after direct treatment or with conditioned media from psoriasin-or LPS-challenged microglia cells was determined. We determined a strong increase in HO-1 mRNA expression after direct and indirect LPS treatment with a significant difference after 6 or 12 h ( Fig. 8e and f) . Psoriasin, on the other hand, induced a substantially lower increase in HO-1 expression after 24 h of direct and indirect treatment without statistical significance.
To confirm an involvement of Nrf2 in psoriasininduced HO-1 expression, we transduced microglial cells with shRNA for Nrf2 to inhibit Nrf2 activation and nontarget shRNA as control. The efficiency of the down- Fig. 3 Psoriasin increased interleukin-6 (IL-6) and tumor necrosis factor a (TNF-a) protein expression in primary glial cells after stimulation with psoriasin or lipopolysaccharide (LPS). Astrocytes (a and c) and microglial cells (b and d) were treated with recombinant psoriasin (300 ng/mL) or with LPS (100 ng/mL) for indicated time periods. IL-6 (a and b) or TNF-a (c and d) protein concentrations were measured in culture supernatants using ELISA technique. The experiments were performed in triplicate. n.s. = not significant, *p < 0.05; **p < 0.01; ***p < 0.001; one-way ANOVA test followed Bonferroni 0 s multiple comparison post hoc test.
regulation was quantified using real time RT-PCR. The shRNA induced a strong significant decrease in Nrf2 mRNA expression in microglial cells (Fig. 8g) . Subsequently, we analyzed HO-1 mRNA expression 12 and 24 h after treatment with psoriasin or LPS. The results revealed a strong increase in HO-1 mRNA expression after 12 h of LPS treatment, whereas psoriasin induced a slight increase after 12 and 24 h in the microglial cells transduced with the non-target shRNA control (Fig. 8h) . The inhibition of Nrf2 resulted in a significant decrease in HO-1 expression for LPS after 12 h, whereas psoriasin treatment showed a lower but not significant decrease in expression (Fig. 8h) .
Psoriasin induced the expression of the neurotrophic factors, BDNF and NGF, in glial cells
In order to analyze potential protective mechanism of psoriasin, we determined the mRNA expression of the neurotrophic factors, BDNF and NGF, in glial cells. These neurotrophic factors are important for neurogenesis in the CNS after brain injuries including bacterial meningitis (Tauber et al. 2005; Grandgirard and Leib 2006; Barichello et al. 2015) . To investigate an effect on the expression of these neurotrophic factors, astrocytes and microglia were treated with 300 ng/mL recombinant psoriasin for 24 h. BDNF and NGF mRNA expression was determined by real time RT-PCR. In astrocytes, stimulation with psoriasin induced a significant increase in BDNF and NGF mRNA compared to untreated controls (Fig. 9a) . A similar effect was observed in microglial cells, where also BDNF and NGF mRNA levels were significantly increased after 24 h of psoriasin exposure (Fig. 9b) . Interestingly, psoriasin had no effect on these neurotrophins after 6 and 12 h of stimulation in both cell types (data not shown). Additionally, we determined the involvement of Nrf2 in psoriasin-or LPS-induced BDNF mRNA expression by Fig. 4 Interleukin-6 (IL-6) and tumor necrosis factor a (TNF-a) mRNA expression is increased in primary glial cells after stimulation with psoriasin or lipopolysaccharide (LPS). Astrocytes (a and c) and microglial cells (d and f) were stimulated with recombinant psoriasin (300 ng/mL) or LPS (100 ng/mL) for indicated time periods. IL-6 mRNA (a and b) or TNF-a (c and d) expression were analyzed using SYBR Green real time RT-PCR and results were compared to the untreated samples (c). Expression raw data from targets were normalized to the expression data from TATA-box binding protein (TBP). Data represent mean + SEM; n = 5; *p < 0.05, **p < 0.01 and ***p < 0.001 as indicated; one-way ANOVA with Bonferroni's multiple comparison post hoc test.
inhibition of Nrf2 using shRNA. LPS treatment resulted in a weak increase in BDNF mRNA expression, whereas psoriasin induced a strong increase in BDNF mRNA levels after 24 h of stimulation in non-target shRNA transduced microglial cells (Fig. 9c) . The inhibition of Nrf2 by shRNA did not affect expression of BDNF after psoriasin or LPS treatment. Tumor necrosis factor a (TNF-a) mRNA and interleukin-10 (IL-10) mRNA expression after direct stimulation or after treatment with conditioned media. Microglial cells were either stimulated directly with recombinant psoriasin (300 ng/mL) or lipopolysaccharide (LPS) (100 ng/mL) or with conditioned media from psoriasin-or LPSchallenged microglia for indicated time periods. TNF-a mRNA (a and b) and IL-10 (c and d) expression were analyzed using real time RT-PCR, results were compared to the untreated samples. Expression raw data from targets were normalized to the expression data from TATAbox binding protein (TBP). Data represent mean + SEM; n = 3; *p < 0.05, **p < 0.01 and ***p < 0.001 as indicated. one-way ANOVA with Bonferroni's multiple comparison post hoc test. Fig. 6 Psoriasin induced nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant response element (ARE) activation in microglial cells. Microglial cells transduced with SIN-lenti-ARE were stimulated with recombinant psoriasin (300 ng/mL) for (a) 6 h, (b) 12 h and (c) 24 h. Sulforaphane (SFN; 6.25 lM) was used as positive control for Nrf2 activation. Untreated cells dealt as control (c). After stimulation the cells were lysed in passive lysis buffer. ARE-depending luminescence signals were measured in a luminometer. Signals were normalized to total protein content [determined by bicinchoninic acid (BCA) assay] and all groups were related to untreated control cells. Data represent mean + SEM; n = 6; *p < 0.05, **p < 0.01 and ***p < 0.001; oneway ANOVA followed by Bonferroni 0 s multiple comparison post hoc test.
Discussion
Psoriasin is a member of the S100 protein family, which consists of EF-hand calcium-binding proteins (Heizmann et al. 2002) , and it also acts as an AMP, mainly against E. coli. Previous work showed its particular importance as an AMP for the maintenance of the skin barrier, but it also functions in epithelial carcinogenesis (Glaser et al. 2005; Hattinger et al. 2013; Hattori et al. 2014) . We recently measured an up-regulation of psoriasin after bacterial infection in astrocytes and meningeal cells (Jansen et al. 2013) . This study analyzed the effects of psoriasin stimulation in the CNS. The results prove an induction of the proinflammatory signal transduction pathway and consecutive pro-inflammatory cytokine production. An activation of protective mechanisms including increased neurotrophic factor expression and induction of anti-inflammatory pathways in glial cells were determined. In detail, exposure to psoriasin resulted in an increase in NFjB translocation in astrocytes and microglial cells. This pathway releases the NFjB subunit p65 which results in the production and secretion of pro-inflammatory cytokines (Li and Verma 2002) . NFjB is important for the regulation of the immune response in the brain (Rivest 2009 ). The induction of NFjB was followed by a time-dependent secretion of the pro-inflammatory cytokines IL-6 and TNF-a in astrocytes and microglia. The release of both cytokines reached a maximum after 4 and 6 h and decreased thereafter back to baseline levels revealing a short-term effect or autodown-regulation to avoid overwhelming pro-inflammatory effects.
The major targets of psoriasin in the CNS are astrocytes and microglia as part of the central innate immune system. Astrocytes are likely to be the major contributors of inflammatory responses within the CNS (Farina et al. 2007) and are strongly involved in the integrity of the blood brain barrier. Resting microglial cells, as macrophages of the brain, change their phenotype by inflammatory stimuli and thereby contribute to inflammation, but also exert neuroprotective effects (Olah et al. 2011) . Our previous findings showed that in the presence of psoriasin, microglia change its phenotype from a resting to an activated state (Jansen et al. 2013) . This study showed that psoriasin-stimulated microglia produce IL-6 and TNF-a, which could elicit the recruitment of cells of the adaptive immune system to the CNS required for pathogen clearance. Especially, TNF-a plays an important role in the initiation of the immune response, strongly supports a faster pathogen elimination and is crucial in bacterial meningitis (Kronfol and Remick 2000; Gerber et al. 2004; Albrecht et al. 2016) . Our results show a direct rather than an indirect effect for TNF-a induction after psoriasin treatment in microglial cells. In contrast, the bacterial cell wall component LPS induced TNF-a expression directly or indirectly. In contrast, IL-6 displays pleiotropic effects as a pro-inflammatory and anti-inflammatory modulator (Scheller et al. 2011) . Our recent study revealed that lack of IL-6 impaired the immune defense and resulted in higher mortality after pneumococcal meningitis resembling the need for the pro-inflammatory effects of this interleukin in this context (Albrecht et al. 2016) . For the anti-inflammatory cytokine IL-10, we did not observe an increase in expression after direct or indirect psoriasin treatment, whereas LPS induced IL-10 expression both directly and indirectly. In this study, an increase in IL-6 and the neurotrophin BDNF was observed although no causal link was proven. Neurotrophic factors act as inducers of neurogenesis and are up-regulated after bacterial meningitis (Tauber et al. 2005) . The missing link between neuroinflammation and the up-regulation of Fig. 8 Heme oxygenase 1 (HO-1) is induced in glial cells by psoriasin treatment. Astrocytes (a) and microglial cells (b) cells were treated with recombinant psoriasin ranking from 100 to 500 ng/mL for 24 h. Untreated cells dealt as control (c). Cells were lysed in buffer and protein was separated by SDS PAGE followed by immunoblotting of HO-1. Shown is one of three independent Western Blot experiments (a and b). Data represent mean + SEM and was evaluated by densitometric quantification (c and d). The ratio between the protein and corresponding loading control bands (b-Actin) was calculated. *p < 0.05, **p < 0.01. Microglial cells were either stimulated directly (e) with recombinant psoriasin (300 ng/mL) or lipopolysaccharide (LPS) (100 ng/mL) or with conditioned media from psoriasin or LPSchallenged microglia cells (f) for indicated time periods and HO-1 expression were analyzed using SYBR Green real time RT-PCR. Microglial cells were transduced with shRNA for Nrf2 or non-target shRNA as control (non-target) and Nrf2 mRNA expression (g) or HO-1 mRNA expression (h) after treatment with recombinant psoriasin (300 ng/mL) or LPS (100 ng/mL) for 12 or 24 h was determined by real time RT-PCR. Expression raw data from targets were normalized to the expression data from TATA-box binding protein (TBP). Data represent mean + SEM; n = 3; *p < 0.05; **p < 0.01 and ***p < 0.001. One-way ANOVA with Bonferroni's multiple comparison post hoc test were used for statistical analysis for C to F; Student's ttest for G and two-way ANOVA with Bonferroni's multiple comparison post hoc test for H.
BDNF remains unclear. The AMP itself could be a potential direct candidate for the missing link. We have already found evidence for another AMP, recombinant CRAMP, being involved in the up-regulation of BDNF and NGF in glial cells under physiologic conditions (Brandenburg et al. 2010) . It can be speculated that induction of neurotrophins may be a general property of AMP such as CRAMP and psoriasin, thereby supporting the protection of neurons and promoting neuronal survival after inflammation.
Recently, we were able to show that the antioxidative transcription factor Nrf2 reduced LPS-induced inflammation in microglial cells (Brandenburg et al. 2009 ). Our current results reveal a significantly higher ARE activity as marker for Nrf2 activity in psoriasin-treated microglial cells. These data verify a psoriasin-induced Nrf2 activation in primary microglia. Nrf2 activation leads to expression of a battery of antioxidant genes (Kweider et al. 2011) . This includes the activation of HO-1 as an Nrf2 target gene. Because of its enzymatic activities, HO-1 exhibits antioxidative and antiinflammatory properties at once. First, HO-1 metabolizes heme to biliverdin that is described to prevent oxidative stress and second, HO-1 produces carbon monoxide that is able to inhibit NFjB (Wei et al. 2010; Piantadosi et al. 2011) . We suggest that the delayed Nrf2 activation (after 12 and 24 h) could be the cause of the relatively fast termination of NFjB translocation and pro-inflammatory cytokine production. Nrf2 activation may ameliorate oxidative stress and could reduce overwhelming inflammation. Interestingly, we identified the ARE sequence as Nrf2-binding sequence in the promoter region of the human and mouse psoriasin. Furthermore, sulforaphane and methysticin as natural Nrf2 activators significantly induced psoriasin mRNA expression in astrocytes, whereas microglial cells showed no induction. Inhibition of Nrf2 by shRNA resulted in a decreased HO-1 mRNA expression, whereas the BDNF mRNA expression remained unchanged. Our results suggest rather a direct than an indirect effect on HO-1 expression after psoriasin treatment. Again, LPS showed a direct and indirect effect on HO-1 expression.
Taken together, this study provides evidence that the AMP psoriasin induces immune functions in murine glial cells as part of the CNS innate immunity. Psoriasin affects the fast initiation of the immune response including early pro-inflammatory cytokine expression. Moreover, it also appears to be involved in the remission of the immune response by activation of antiinflammatory signaling pathways, which may help to prevent a harmful excessive immune response. In this context, the activation of Nrf2 as an antioxidant transcription factor appears to be important for induction of anti-inflammatory pathways. Therefore, adjunctive application of the AMP psoriasin could be an interesting approach for modulating the immune response positively during the course of CNS infections.
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